ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 127 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $261 | -46.3% | 3,685 | 0.0% | 0.00% | – |
| Q3 2023 | $486 | -74.1% | 3,685 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $1,879 | -19.1% | 3,685 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,322 | -63.4% | 3,685 | 0.0% | 0.00% | -66.7% |
| Q4 2022 | $6,338 | +5.6% | 3,685 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $6,000 | +20.0% | 3,685 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $5,000 | +150.0% | 3,685 | 0.0% | 0.00% | +200.0% |
| Q1 2022 | $2,000 | -50.0% | 3,685 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $4,000 | -42.9% | 3,685 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $7,000 | -12.5% | 3,685 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $8,000 | -38.5% | 3,685 | 0.0% | 0.00% | -55.6% |
| Q1 2021 | $13,000 | +44.4% | 3,685 | 0.0% | 0.01% | +28.6% |
| Q4 2020 | $9,000 | 0.0% | 3,685 | 0.0% | 0.01% | -22.2% |
| Q1 2020 | $9,000 | – | 3,685 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 15,151,516 | $38,182,000 | 7.99% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 10,406,850 | $26,225,000 | 4.02% |
| MILLER VALUE PARTNERS, LLC | 12,385,586 | $31,211,000 | 1.12% |
| CHIRON CAPITAL MANAGEMENT, LLC | 201,470 | $508,000 | 0.41% |
| Sargent Investment Group, LLC | 289,025 | $728,000 | 0.26% |
| MAGNOLIA CAPITAL ADVISORS LLC | 80,542 | $404,000 | 0.16% |
| XTX MARKETS LLC | 11,086 | $28,000 | 0.14% |
| Virtus ETF Advisers LLC | 99,108 | $250,000 | 0.13% |
| Old West Investment Management, LLC | 210,226 | $529,000 | 0.12% |
| EQUITEC PROPRIETARY MARKETS, LLC | 31,300 | $79,000 | 0.06% |